Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jun 5 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 1,843 | $167.31 | $308.4K | -10.4% | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 5,829 | $166.56 | $970.9K | -24.8% | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 6,896 | $165.79 | $1.1M | -22.7% | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 2,549 | $164.44 | $419.2K | -7.7% | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 7,883 | $163.81 | $1.3M | -19.3% | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 10,000 | $79.79 | $797.9K | +32.4% | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 15,000 | $53.64 | $804.6K | +94.6% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 2,567 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 3,318 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 3,318 | — | — | +26.5% | Open the original filing on SEC.gov |